ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

One #cancertreatment that reduces cancer fatigue is Ginseng, Mayo Clinic study finds

June 4, 2012 11:27 am by | 0 Comments

fatigue, tired

Fatigue is one of the most common effects of cancer and #cancertreatment.

Now, cancer-related fatigue appears to have an enemy. A Mayo Clinic study found that high doses of the herb ginseng was effective in reducing cancer-related fatigue over two months when compared with a placebo.

Mayo Researchers evaluated 340 patients who had either completed cancer treatment or were undergoing treatment at one of 40 community medical centers. Study participants would receive a daily dosage of a placebo or 2,000 milligrams of ginseng administered in capsules containing pure, ground American ginseng root.

Advertisement

That is markedly different from off-the-shelf ginseng, which sometimes is processed with ethanol, giving it characteristics similar to estrogen. That is harmful for breast cancer patients, warned researcher Debra Barton of the Mayo Clinic Cancer Center, in a Mayo news release.

Ginseng’s effect on fatigue showed marked improvement over time from a slight improvement at four weeks to significant improvement at eight weeks.

“After eight weeks, we saw a 20-point improvement in fatigue in cancer patients, measured on a 100-point, standardized fatigue scale,” Barton said.

Barton and other researchers could find no apparent side effects from the herb.

Aside from reducing fatigue, American ginseng also appears to have other cancer-fighting abilities. According to a 2010 lab study, American ginseng extract ledcultures of colorectal cancer cells to die, implying that the herb may have an anticancer properties.

Here is a video of Mayo’s study:

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
LabCorp builds up specialty testing unit with $241M MEDTOX acquisition
Close